- IDEXX Laboratories acquires CoVetAI: what it means for IDEXX Laboratories stock
AD HOC NEWS · Oct 7, 2026
- IDEXX Laboratories (Nasdaq:IDXX) - Stock Analysis
Simply Wall Street · Oct 6, 2026
- IDEXX Laboratories to Release 2026 Third Quarter Financial Results | IDXX Stock News
Latest News | Stock Titan · Oct 1, 2026
IDEXX Laboratories announced plans to release its third quarter 2026 financial results on a specified upcoming date. This scheduled report provides investors with key visibility into the company's financial performance and diagnostic market demand.
- Chicago Pacific Founders Pet Fund Announces Exit of CoVetAI Following Acquisition by IDEXX Laboratories | IDXX Stock News
Latest News | Stock Titan · Sep 30, 2026
Chicago Pacific Founders announced the exit of CoVetAI following its acquisition by IDEXX Laboratories. This acquisition expands IDEXX's capabilities in veterinary workflow software and clinical decision support.
- Chicago Pacific Founders Pet Fund Announces Exit of CoVetAI Following Acquisition by IDEXX Laboratories
PR Newswire · Sep 30, 2026
- What Does Today’s Signal Mean for IDEXX Laboratories (NASDAQ:IDXX)?
Kalkine Media · Sep 30, 2026
- Did Wider Parasite Testing Just Shift IDEXX Stock Investment Narrative?
simplywall.st · Sep 26, 2026
- Did Wider Parasite Testing Just Shift IDEXX Stock Investment Narrative?
Simply Wall Street · Sep 26, 2026
- Did Wider Parasite Testing Just Shift IDEXX Stock Investment Narrative?
Simply Wall St · Sep 26, 2026
IDEXX Laboratories expanded its Faecal Dx antigen testing platform in the UK to include taeniid tapeworms, broadening parasite detection during routine veterinary visits. The update deepens the company's role in routine preventive care and supports recurring diagnostic usage.
- IDEXX Laboratories (IDXX) Could Be 26% Undervalued Following UK Faecal Dx Expansion
simplywall.st · Sep 24, 2026
- Should You Continue to Hold IDXX Stock in Your Portfolio?
Zacks / TradingView · Sep 23, 2026
An analysis of IDEXX Laboratories highlights steady Companion Animal Group (CAG) recurring revenue growth, cloud software adoption, and instrument placement expansion. However, foreign exchange headwinds and soft U.S. veterinary clinic visits remain notable constraints.
- IDEXX Laboratories stock gains 1.16 percent as valuation holds
AD HOC NEWS · Sep 22, 2026
- IDEXX Laboratories Highlights Diagnostic Pipeline, Reaffirms Long-Term Growth Targets
Yahoo Finance · Sep 20, 2026
IDEXX Laboratories presented its latest diagnostic pipeline developments and reaffirmed its long-term financial growth targets. This update provides investors with confidence in the company's strategic direction and product innovation roadmap.
- IDEXX Laboratories Highlights Diagnostic Pipeline, Reaffirms Long-Term Growth Targets
MarketBeat · Sep 20, 2026
IDEXX Laboratories highlighted its diagnostic pipeline and reaffirmed its long-term growth targets at a recent healthcare conference. The company remains confident in double-digit organic revenue growth driven by expanding veterinary diagnostic adoption.
- IDEXX Laboratories stock gains attention after CoVetAI deal and Stifel Buy rating
AD HOC NEWS · Sep 20, 2026
- IDEXX (IDXX) Bets an AI Scribe Can Sell More Pet Diagnostics
Yahoo Finance · Sep 19, 2026
IDEXX is launching an AI-powered medical scribe designed to streamline veterinary workflows and drive sales of its diagnostic tests. This product rollout strengthens the company's position in veterinary clinical decision support and diagnostic reporting.
- Should Faecal Dx Expansion Require Action From IDEXX Stock Investors?
simplywall.st · Sep 19, 2026
- Why Is the Market Reassessing IDEXX Laboratories (IDXX)?
Kalkine Media · Sep 19, 2026
- IDEXX Laboratories Acquires CoVetAI to Advance Veterinary Workflow Intelligence
myvetcandy.com · Sep 17, 2026
- IDEXX Laboratories stock gains as CoVetAI deal and new parasite tests bolster growth narrative
ad-hoc-news.de · Sep 17, 2026